Business Context and Reporting Period
IM Cannabis Corp. filed a Form 6-K as a foreign private issuer on May 12, 2022. The filing covers the month of May 2022 and identifies the company’s principal executive offices in Kibbutz Glil Yam, Israel.
The filing lists interim consolidated financial statements and management’s discussion and analysis for the three months ended March 31, 2022, but the submitted text contains only the filing cover page and exhibit index. The underlying financial information is not provided.
Financial Metrics
The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, cash balances, operating expenses, or other financial metrics.
Material Changes Versus Prior Period
The filing text does not provide comparative financial data or describe material changes from the prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not include management commentary, guidance, outlook, risk disclosures, contingencies, or unusual items. These matters may be addressed in the listed exhibits, including the interim financial statements and management’s discussion and analysis, which are not included in the supplied content.
Key Facts to Verify
- Review Exhibit 99.2 for the complete interim consolidated financial statements for the three months ended March 31, 2022.
- Review Exhibit 99.3 for revenue trends, operating results, liquidity, cash usage, debt, commitments, and management’s commentary.
- Verify all comparative figures and material changes against the prior-year first quarter.
- Review Exhibits 99.4 and 99.5 for the CFO and CEO certifications of the interim filings.